These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18974472)

  • 1. Proton pump inhibitors are an independent risk factor for an increased length of hospital stay in patients with Clostridium difficile infection.
    Nachnani JS; Bulchandani D; Allen MJ
    Indian J Gastroenterol; 2008; 27(4):171-2. PubMed ID: 18974472
    [No Abstract]   [Full Text] [Related]  

  • 2. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
    Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
    Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
    McDonald EG; Milligan J; Frenette C; Lee TC
    JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fidaxomicin for Clostridium difficile infection.
    Linsky A; Gupta K; Hermos JA
    N Engl J Med; 2011 May; 364(19):1875; author reply 1875-6. PubMed ID: 21561361
    [No Abstract]   [Full Text] [Related]  

  • 9. Multimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS).
    Ticinesi A; Nouvenne A; Folesani G; Prati B; Morelli I; Guida L; Turroni F; Ventura M; Lauretani F; Maggio M; Meschi T
    BMJ Open; 2015 Oct; 5(10):e009316. PubMed ID: 26503394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Proton Pump Inhibitors and Risk of Nosocomial Clostridium Difficile Infection in Hospitalized Elderly Adults.
    Depoorter L; Verhaegen J; Joosten E
    J Am Geriatr Soc; 2016 Mar; 64(3):667-9. PubMed ID: 27000353
    [No Abstract]   [Full Text] [Related]  

  • 11. Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.
    Roughead EE; Chan EW; Choi NK; Griffiths J; Jin XM; Lee J; Kimura M; Kimura T; Kubota K; Lai EC; Man KK; Nguyen TA; Ooba N; Park BJ; Sato T; Shin JY; Wang T; Wong IC; Yang YK; Pratt NL
    Expert Opin Drug Saf; 2016 Dec; 15(12):1589-1595. PubMed ID: 27645304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving Insights Into the Epidemiology and Control of Clostridium difficile in Hospitals.
    Caroff DA; Yokoe DS; Klompas M
    Clin Infect Dis; 2017 Oct; 65(7):1232-1238. PubMed ID: 28520953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.
    Dial S; Alrasadi K; Manoukian C; Huang A; Menzies D
    CMAJ; 2004 Jul; 171(1):33-8. PubMed ID: 15238493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of risk factors of Clostridiumdifficile infection in patients hospitalized in the teaching hospital in 2008.
    Dulny G; Zalewska M; Mlynarczyk G
    Przegl Epidemiol; 2013; 67(3):445-50, 547-51. PubMed ID: 24340558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System.
    Watson T; Hickok J; Fraker S; Korwek K; Poland RE; Septimus E
    Clin Infect Dis; 2018 Jun; 66(12):1957-1959. PubMed ID: 29272341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and medical management of Clostridium difficile infection.
    Shannon-Lowe J; Matheson NJ; Cooke FJ; Aliyu SH
    BMJ; 2010 Mar; 340():c1296. PubMed ID: 20228142
    [No Abstract]   [Full Text] [Related]  

  • 20. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.